Mifepristone inhibits IGF-1 signaling pathway in the treatment of uterine leiomyomas

PURPOSE: To investigate the role of IGF-1 signaling pathway in the treatment of uterine leiomyomas with mifepristone. PATIENTS AND METHODS: From October 2015 to December 2018, 50 patients with uterine leiomyoma were included in this study. Overexpression or siRNA of IGF-1 in primary human uterine le...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Qi, Zou, Shuangwei, Sheng, Bo, Zhao, Menghuang, Sun, Lu-Zhe, Zhu, Xueqiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6731989/
https://www.ncbi.nlm.nih.gov/pubmed/31564832
http://dx.doi.org/10.2147/DDDT.S212157

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6731989/
https://www.ncbi.nlm.nih.gov/pubmed/31564832
http://dx.doi.org/10.2147/DDDT.S212157

Ejemplares similares